Latest news
Pentixapharm Holding AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution - TradingViewTradingView · Fri, 07 Aug 2026 06:00:00 GMTPentixapharm Reports Second Quarter and First Half 2026 Results and Advances Phase 3 Panda Program - TradingViewTradingView · Thu, 06 Aug 2026 06:00:00 GMTOriginal-Research: Pentixapharm Holding AG (von NuWays AG): BUY - TradingViewTradingView · Fri, 31 Jul 2026 07:00:05 GMTPentixapharm Holding AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution - TradingViewTradingView · Thu, 30 Jul 2026 20:46:23 GMTPentixapharm Holding discloses 35,815,689 total voting rights - BitgetBitget · Thu, 30 Jul 2026 07:00:00 GMTPentixapharm raises €20.4M for Phase 3 diagnostic trial - European Biotechnology MagazineEuropean Biotechnology Magazine · Tue, 28 Jul 2026 07:00:00 GMTPentixapharm Holding AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] - TradingViewTradingView · Mon, 27 Jul 2026 20:34:23 GMTPentixapharm Holding AG completes rights offering and private placement with significant oversubscription generating gross proceeds of approx. EUR 20.4 Million already today - TradingViewTradingView · Mon, 27 Jul 2026 18:40:54 GMT